The U.S. Department of Health and Human Services (HHS) is re-evaluating its stance on fluoride in drinking water by reconvening the Community Preventive Services Task Force, an independent panel of health experts. This move follows Health Secretary Robert F. Kennedy Jr.’s recent statement in Salt Lake City, indicating plans to halt the Centers for Disease Control and Prevention’s recommendation for community water fluoridation.
Fluoride, commonly added to public water supplies to prevent tooth decay, has been a controversial topic for decades. While the American Dental Association continues to support fluoridation as an effective dental health measure, concerns about potential health risks have gained traction.
The Environmental Protection Agency (EPA) will also review new scientific data on fluoride’s health effects. EPA Administrator Lee Zeldin confirmed that this effort is in collaboration with HHS, with the goal of re-evaluating the agency’s current enforceable fluoride limit of 4.0 milligrams per liter (mg/L). Currently, the U.S. Public Health Service recommends maintaining levels below 0.7 mg/L. Studies show that exposure above 1.5 mg/L can increase risks of bone fractures, thyroid dysfunction, and neurological damage.
In a landmark move, Utah became the first state to ban fluoride in public water systems after Governor Spencer Cox signed new legislation last month. The decision faced strong opposition from health experts and organizations, including the American Dental Association.
As of 2022, about 63% of Americans receive fluoridated water through their municipal systems. A 2024 federal court ruling ordered the EPA to tighten its standards, citing unacceptable health risks to children under current fluoride levels. While Kennedy claims links between fluoride and conditions like cancer, his statements remain unsubstantiated by definitive scientific evidence.


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Trump’s Iraq Envoy Mark Savaya Ousted Amid U.S.-Iraq Tensions Over Iran Influence
Russian Drone Strike Kills Miners as Ukraine Pushes for Peace Talks Amid Energy Crisis
Costa Rica Election: Laura Fernandez Wins Presidency as PPSO Secures Congressional Majority
Venezuela and U.S. Move Toward Renewed Diplomatic Relations
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Rafah Border Crossing to Reopen for Palestinians as Israel Coordinates with Egypt and EU
Peter Mandelson Resigns from Labour Party Amid Renewed Jeffrey Epstein Links
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



